TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB-CAMH), today announced that four scientific papers addressing Microvolt T-Wave Alternans (MTWA) technology as a predictor of arrhythmic events and a means of stratifying a patient’s risk of sudden cardiac death have been accepted for publication in an upcoming supplement to the journal HeartRhythm, the Official Journal of the Heart Rhythm Society (HRS). The preliminary manuscripts of the papers have been made available on the HRS website at http://www.heartrhythmjournal.com/inpress.
